These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28013436)

  • 1. Opiorphin in burning mouth syndrome patients: a case-control study.
    Salarić I; Sabalić M; Alajbeg I
    Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study.
    Boucher Y; Braud A; Dufour E; Agbo-Godeau S; Baaroun V; Descroix V; Guinnepain MT; Ungeheuer MN; Ottone C; Rougeot C
    Clin Oral Investig; 2017 Sep; 21(7):2157-2164. PubMed ID: 27834029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and control subjects.
    Alajbeg IZ; Vrbanovic E; Alajbeg I; Orabovic I; Naka K; Mrla A; Boucher Y
    Clin Oral Investig; 2024 Apr; 28(5):246. PubMed ID: 38589630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome.
    Kim HI; Kim YY; Chang JY; Ko JY; Kho HS
    Oral Dis; 2012 Sep; 18(6):613-20. PubMed ID: 22533537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
    Suh KI; Kim YK; Kho HS
    Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome.
    Kang JH; Kim YY; Chang JY; Kho HS
    Arch Oral Biol; 2017 Jun; 78():58-64. PubMed ID: 28199919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of the acid-soluble fraction of whole and major gland saliva in burning mouth syndrome patients.
    Cabras T; Manconi B; Castagnola M; Sanna MT; Arba M; Acharya S; Ekström J; Carlén A; Messana I
    Arch Oral Biol; 2019 Feb; 98():148-155. PubMed ID: 30496935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary opiorphin in dental pain: A potential biomarker for dental disease.
    Ozdogan MS; Gungormus M; Ince Yusufoglu S; Ertem SY; Sonmez C; Orhan M
    Arch Oral Biol; 2019 Mar; 99():15-21. PubMed ID: 30590229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines.
    Pekiner FN; Gümrü B; Demirel GY; Ozbayrak S
    J Oral Pathol Med; 2009 Mar; 38(3):269-75. PubMed ID: 19141055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva on the oral mucosa and whole saliva in women diagnosed with burning mouth syndrome.
    Acharya S; Hägglin C; Jontell M; Wenneberg B; Ekström J; Carlén A
    Oral Dis; 2018 Nov; 24(8):1468-1476. PubMed ID: 29917294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineral and trace element analysis of saliva from patients with BMS: a cross-sectional prospective controlled clinical study.
    López-Jornet P; Juan H; Alvaro PF
    J Oral Pathol Med; 2014 Feb; 43(2):111-6. PubMed ID: 23869755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic changes of saliva and taste in burning mouth syndrome patients.
    Imura H; Shimada M; Yamazaki Y; Sugimoto K
    J Oral Pathol Med; 2016 Mar; 45(3):231-6. PubMed ID: 26293497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics.
    Ji EH; Diep C; Liu T; Li H; Merrill R; Messadi D; Hu S
    Mol Pain; 2017 Jan; 13():1744806916686796. PubMed ID: 28326926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary opiorphin levels in denture-related traumatic ulcers.
    Ozdogan MS; Gungormus M
    Oral Dis; 2024 Jul; 30(5):3136-3141. PubMed ID: 37793134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile.
    de Moura SA; de Sousa JM; Lima DF; Negreiros AN; Silva Fde V; da Costa LJ
    Gerodontology; 2007 Sep; 24(3):173-6. PubMed ID: 17696895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome.
    Simcić D; Pezelj-Ribarić S; Grzić R; Horvat J; Brumini G; Muhvić-Urek M
    Mediators Inflamm; 2006; 2006(1):54632. PubMed ID: 16864905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burning mouth syndrome: a therapeutic approach involving mechanical salivary stimulation.
    de Souza FT; Amaral TM; dos Santos TP; Abdo EN; Aguiar MC; Teixeira AL; Kummer AM; Abreu MH; Silva TA
    Headache; 2012 Jun; 52(6):1026-34. PubMed ID: 22084903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome.
    Zidverc-Trajkovic J; Stanimirovic D; Obrenovic R; Tajti J; Vécsei L; Gardi J; Németh J; Mijajlovic M; Sternic N; Jankovic L
    J Oral Pathol Med; 2009 Jan; 38(1):29-33. PubMed ID: 19192048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantification of opiorphin in human saliva.
    Brkljačić L; Sabalić M; Salarić I; Jerić I; Alajbeg I; Nemet I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3920-6. PubMed ID: 22119435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome.
    Tvarijonaviciute A; Aznar-Cayuela C; Rubio CP; Ceron JJ; López-Jornet P
    J Oral Pathol Med; 2017 May; 46(5):387-392. PubMed ID: 27862315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.